Nova Eye Medical Limited (ASX:EYE)
Australia · Delayed Price · Currency is AUD 0.1400
+0.0050 (3.70%)
Sep 17, 2026, 3:53 PM AEST
Nova Eye Medical Market Cap
Nova Eye Medical has a market cap or net worth of 38.46 million as of September 17, 2026. Its market cap has decreased by -9.98% in one year.
Market Cap
38.46M
Enterprise Value
39.89M
Revenue
34.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
ChartMarket Cap Chart
Since March 9, 1998, Nova Eye Medical's market cap has increased from 785.81K to 38.46M, an increase of 4,794.07%. That is a compound annual growth rate of 14.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 38.46M | 1.91% |
| Dec 31, 2025 | 37.74M | 2.97% |
| Dec 31, 2024 | 36.65M | -19.89% |
| Dec 29, 2023 | 45.75M | 12.00% |
| Dec 29, 2022 | 40.85M | -17.46% |
| Dec 31, 2021 | 49.49M | -2.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SomnoMed | 73.62M |
| Cyclopharm | 62.87M |
| Epiminder | 60.67M |
| Compumedics | 46.94M |
| Cleo Diagnostics | 42.50M |
| HeraMED | 38.24M |
| OncoSil Medical | 37.25M |
| Control Bionics | 33.13M |